abstract |
The present invention provides a fusion protein of ETA antibody and TGF-β Trap. This article also provides a pharmaceutical composition of ETA antibody and TGF-β Trap fusion protein. This document further provides a method for treating, preventing or ameliorating one or more symptoms of pulmonary hypertension, pulmonary hypertension, pulmonary fibrosis, or cardiovascular fibrosis by using the ETA antibody and TGF-β Trap fusion protein. |